The first Russian pharmacoepidemiological study of arterial hypertension
https://doi.org/10.18705/1607-419X-2003-9-4-128-133
Abstract
In some regions of Russia, the prescription of different antihypertensive drugs by physicians was analyzed. This made it possible to assess their experience and knowledge and to direct ways to further improvements of the quality of care to patients with arterial hypertension. Despite the recommendation that diuretics and ß-blockers should be used as the first-line drugs, these agents are less frequently used due to the fact that pharmaceutical companies make effective marketing for ACE inhibitors and Ca2+-channel blockers. Physicians more commonly prefer a combination of drugs, but this slightly deteriorates the adherence of patients to treatment. Combined drugs are sometimes used. The present-day medical treatment of arterial hypertension in the Russian Federation is mainly determined by the recommendations made by the All-Russian Scientific Society of Cardiology in 2001; however, the choice of a drug should be primarily based on a comprehensive assessment of risk factors available in a patient.
About the Authors
M. V. Leonova
Аналитическая группа исследования «ПИФАГОР»
Russian Federation
Russian Federation
D. Yu. Belousov
Аналитическая группа исследования «ПИФАГОР»
Russian Federation
Russian Federation
References
1. Здоровье населения России и деятельность учреждений здравоохранения 1998 (1999) г. (статистические материалы). М., 1999 (2000).
2. The Sixth Report of joint National Committee on the Prevention, Detection. Evaluation, and Treatment of High Blood Pressure, 1997.
3. National Institutes of Health, National Heart, Lung and Blood Institute Report No. 98-4080. Word Health Organization/International Society of Hypertension Guidelines for the Management of Hypertension, WHO/ISH Guidelines Subcommittee, 1999.
4. Национальные рекомендации по профилактике, диагностике и лечению артериальной гипертонии. Всероссийское научное общество кардиологов. Российский национальный конгресс кардиологов, Москва, 11 октября 2001 г. www.cardiolog.ru/medical/recom-artgip.asp.
5. Опросник ПИФАГОР. Качествен. клин. Практика. 2002; 1: 115-6.
6. Захаревич О.А., Леонова М.В. Фармакоэпидемиологическое исследование приверженности врачей к назначению гипотензивных лекарственных средств. Качествен. клин. Практика. 2001; 1: 61-4.
7. История лекарственных препаратов июль 2001 — июль 2002 г., www.d-rision.ru.
8. Psaty B.M., Heckbert S.R., Koepsell T.D., Siscovick D.S., Raghunathan T.E., Weiss N.S., Rosendaal F.R., Lemaitre R.N., Smith N.L., Wahl P.W. et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA. 1995 Aug 23-30; 274( 8): 620-5.
9. Ambrosioni E., Leonetti G., Pessina A.C., Rappelli A., Trimarco B., Zanchetti A. Patterns of hypertension management in Italy: results of a pharmacoepidemiological survey on antihypertensive therapy. Scientific Committee of the Italian Pharmacoepidemiological Survey on Antihypertensive Therapy. J Hypertens. 2000 Nov;18(11):1691-9.
10. Crucitti A., Cecchi E., Gensini G.F., Simone I., Conti A., Giallioni S., Pedone C., Pahor M., Mugelli A. Use of antihypertensive drugs in the Italian hospitals. GIFA group. Gruppo Italiano di Farmacoepidemiologia nell'Anziano. Pharmacol Res. 2000 Feb; 41 (2): 249-53.
11. Gasse C., Stieber J., Doreng A., Keil U., Hense H.W. Population trends in antihypertensive drug use: results from the MONICA Augsburg Project 1984 to 1995. J Clin Epidemiol. 1999 Jul; 52 (7): 695-703.
12. Gasse C., Hense H.W., Stieber J., Doring A., Liese A.D., Keil U. Assessing hypertension management in the community: trends of prevalence, detection, treatment, and control of hypertension in the MONICA Project, Augsburg 1984-1995. J Hum Hypertens. 2001 Jan; 15 (1): 27-36.
13. Lapeyre-Mestre M., Sulem P., Chastan E., Niezborala M.,Briant D., Jansou P., Sanguignol F., Montastruc J.L. Consumption of antihypertensive agents in obese patients: a cross-sectional study in a sample of 3,291 wage-earners in the Toulous region. Arch Mal Coeur Vaiss. 2000 Aug;93 (8): 925-9.
14. Puras A., Sanchis C., Artigao L.M., Divison J.A. Prevalence, awareness, treatment, and control of hypertension in a Spanish population. Eur J Epidemiol 1998 Jan;14 (1): 31-6.
15. Aranda P., Tamargo J., Aranda F.J., Luque M., Lopez-Garcia-Franco A. Use and adverse reactions of antihypertensive drugs in Spain. Part I of the RAAE Study. Blood Press Suppl. 1997; 1: 11-6.
16. Jabary N.S., Herrero A.M., Gonzalez J.A. The use of antihypertensive therapy in Spain (1986-1994). Am J Hypertens. 2000 Jun;13 (6 Pt 1): 607-10.
17. Saruta T. Hypertension in Japan. Nikkei Medical 2001: 7: 58-63.
Review
For citations:
Leonova M.V., Belousov D.Yu. The first Russian pharmacoepidemiological study of arterial hypertension. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2003;9(4):128-133. (In Russ.) https://doi.org/10.18705/1607-419X-2003-9-4-128-133
Views:
782
Email this article 